Pacira Pharmaceuticals Announces Timing for 2016 Financial Results Webcast and Conference Call
Feb 16, 2017 12:30 pm UTC| Business
PARSIPPANY, N.J., Feb. 16, 2017 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that financial results for the company’s fourth quarter and year ended December 31, 2016 will be released before the market...
Feb 16, 2017 12:15 pm UTC| Business
Hollywood, Feb. 16, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST) (ETST or the Company), an innovative biotech company, which focuses on cannabis-industrial hemp, cannabinoid research and development, nutraceuticals...
Global $6 Billion Electric UAV Drones Market 2017-2027
Feb 16, 2017 12:06 pm UTC| Business
Dublin, Feb. 16, 2017 -- Research and Markets has announced the addition of the "Electric UAV Drones: Autonomous, Energy Independent 2017-2027" report to their offering. It is...
Feb 16, 2017 12:05 pm UTC| Business
INDIANAPOLIS, Feb. 16, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Endurance International Group Reports 2016 Fourth Quarter and Full Year Results
Feb 16, 2017 12:05 pm UTC| Business
Fiscal Year 2016 GAAP revenue of $1.111 billionNet loss of $81.2 millionAdjusted EBITDA of $288.4 millionCash flow from operations of $155.0 millionFree cash flow of $111.8 millionTotal subscribers on platform were...
Feb 16, 2017 12:02 pm UTC| Business
- Phase 2 Data Now Expected Ahead of Schedule in 3Q 2017 - GERMANTOWN, Md., Feb. 16, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies...
Agios Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key 2017 Milestones
Feb 16, 2017 12:01 pm UTC| Business
- Ivosidenib (AG-120) NDA Submission for IDH1m R/R AML Planned by Year End 2017; First Phase 1 Expansion Data Expected in the Second Half of 2017 - - AG-348 Pivotal Trial Design Update Expected in the Third Quarter of...